Repare Therapeutics downgraded by Morgan Stanley with a new price target
$RPTX
Biotechnology: Pharmaceutical Preparations
Health Care
Morgan Stanley downgraded Repare Therapeutics from Overweight to Equal-Weight and set a new price target of $15.00 from $28.00 previously